Johnson & Johnson exec signs on for Algorae AI drug development
Johnson & Johnson exec Dr Sarah Siggins has signed on for ASX-listed Algorae Pharmaceuticals’ hunt to create drug combinations recommended by AI to tackle hard to beat diseases.
Publicado el: 2024-11-28 04:45:33
Autor: The Sydney Morning Herald, Fuente: The Sydney Morning Herald
Compartir: 
